CKS1B and lung cancer: Wang et al. observed that CKS1B overexpression in lung cancer cells achieved through lentiviral infection enhanced drug resistance by inhibiting cisplatin (CDDP)- and doxorubicin (DOX)-induced apoptosis, supporting the critical role of CKS1B in lung cancer progression (25).